These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

529 related articles for article (PubMed ID: 19161833)

  • 1. Therapeutic approaches to ion channel diseases.
    Camerino DC; Desaphy JF; Tricarico D; Pierno S; Liantonio A
    Adv Genet; 2008; 64():81-145. PubMed ID: 19161833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Channels active in the excitability of nerves and skeletal muscles across the neuromuscular junction: basic function and pathophysiology.
    Goodman BE
    Adv Physiol Educ; 2008 Jun; 32(2):127-35. PubMed ID: 18539851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skeletal muscle channelopathies.
    Jurkat-Rott K; Lerche H; Lehmann-Horn F
    J Neurol; 2002 Nov; 249(11):1493-502. PubMed ID: 12420087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epilepsy and ionic channels.
    Roll P; Szepetowski P
    Epileptic Disord; 2002 Sep; 4(3):165-72. PubMed ID: 12446218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrophysiology and molecular pharmacology of muscle channelopathies.
    Jurkat-Rott K; Lehmann-Horn F
    Rev Neurol (Paris); 2004 May; 160(5 Pt 2):S43-8. PubMed ID: 15269660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human skeletal muscle sodium channelopathies.
    Vicart S; Sternberg D; Fontaine B; Meola G
    Neurol Sci; 2005 Oct; 26(4):194-202. PubMed ID: 16193245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electromyography guides toward subgroups of mutations in muscle channelopathies.
    Fournier E; Arzel M; Sternberg D; Vicart S; Laforet P; Eymard B; Willer JC; Tabti N; Fontaine B
    Ann Neurol; 2004 Nov; 56(5):650-61. PubMed ID: 15389891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment in myotonia and periodic paralysis.
    Meola G; Sansone V
    Rev Neurol (Paris); 2004 May; 160(5 Pt 2):S55-69. PubMed ID: 15269662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmune channelopathies.
    Buckley C; Vincent A
    Nat Clin Pract Neurol; 2005 Nov; 1(1):22-33. PubMed ID: 16932489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ion channel functional candidate genes in multigenic neuropsychiatric disease.
    Gargus JJ
    Biol Psychiatry; 2006 Jul; 60(2):177-85. PubMed ID: 16497276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic neurological channelopathies.
    Hanna MG
    Nat Clin Pract Neurol; 2006 May; 2(5):252-63. PubMed ID: 16932562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Voltage-gated sodium channels: action players with many faces.
    Koopmann TT; Bezzina CR; Wilde AA
    Ann Med; 2006; 38(7):472-82. PubMed ID: 17101538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies to identify ion channel modulators: current and novel approaches to target neuropathic pain.
    Birch PJ; Dekker LV; James IF; Southan A; Cronk D
    Drug Discov Today; 2004 May; 9(9):410-8. PubMed ID: 15081958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ion channels and penile erection].
    Liu J; Chen J
    Zhonghua Nan Ke Xue; 2004 Jun; 10(6):403-6, 410. PubMed ID: 15267199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Channelopathies: episodic disorders of the nervous system.
    Ptacek L
    Novartis Found Symp; 2002; 241():87-104; discussion 104-8, 226-32. PubMed ID: 11771653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ion channel modulators: new targets and new indications for old targets.
    Priest B; Kaczorowski GJ; Garcia ML
    Curr Opin Drug Discov Devel; 2006 Sep; 9(5):587-94. PubMed ID: 17002219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic scope of modulation of non-voltage-gated cation channels.
    Li S; Gosling M; Poll CT; Westwick J; Cox B
    Drug Discov Today; 2004 Dec; 9(24):1045-54. PubMed ID: 15582793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic scope of modulation of non-voltage-gated cation channels.
    Li S; Gosling M; Poll CT; Westwick J; Cox B
    Drug Discov Today; 2005 Jan; 10(2):129-37. PubMed ID: 15718162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Voltage-sensitive ion channels and cancer.
    Fiske JL; Fomin VP; Brown ML; Duncan RL; Sikes RA
    Cancer Metastasis Rev; 2006 Sep; 25(3):493-500. PubMed ID: 17111226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathomechanisms in channelopathies of skeletal muscle and brain.
    Cannon SC
    Annu Rev Neurosci; 2006; 29():387-415. PubMed ID: 16776591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.